National Institutes of Health OLAO
FederalMD
Posted
Oct 28, 2026
Nov 6, 2026
RNA sequencing and whole genome sequencing services
The National Institutes of Health’s National Cancer Institute intends to award a sole-source, firm-fixed-price purchase order to Plasmidsaurus Inc. for RNA sequencing and whole genome sequencing services. The requirement covers wild-type and drug-treated cell lines and CRISPR-related research samples. This is a notice of intent rather than a competitive request for proposals, but interested vendors may submit capability statements demonstrating that they can meet the requirements.
